LTGO-33

N/A

Report date: 2024/06/06 17:59:21
NME

Base Information

Drug NameLTGO-33
Drug Alias NameLTGO-33
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium channel protein type X alpha subunit inhibitors
TargetsSodium channel protein type X alpha subunit
Therapy Area/IndicationsPain
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesLatigo Biotherapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesLatigo Biotherapeutics Inc
Inactive CompaniesN/A
Active IndicationsPain
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A